Valuation: Biogen Inc.

Market Cap 36.08B 32.37B 29.92B 27.1B 50.63B 3,436B 51.25B 358B 143B 1,798B 135B 133B 5,708B P/E 2026 *
42.6x
P/E 2027 * 21.7x
Enterprise Value 42.23B 37.89B 35.03B 31.73B 59.27B 4,022B 59.99B 419B 167B 2,105B 158B 155B 6,682B EV / Sales 2026 *
4.02x
EV / Sales 2027 * 3.65x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+3.60%
1 week-0.71%
Current month+11.58%
1 month+11.00%
3 months+20.46%
6 months+29.66%
Current year+43.21%
1 week 243.03
Extreme 243.03
258.78
1 month 215.73
Extreme 215.73
258.78
Current year 160.36
Extreme 160.3645
258.78
1 year 138
Extreme 138
258.78
3 years 110.04
Extreme 110.035
268.3
5 years 110.04
Extreme 110.035
319.76
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 2022-11-13
Director of Finance/CFO 60 2025-02-28
Chief Tech/Sci/R&D Officer - 2024-10-27
Director TitleAgeSince
Director/Board Member 69 2010-03-22
Director/Board Member 77 2009-12-31
Director/Board Member 72 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
10/2/26 Exercice

Controller/Auditor

62 0.0000%
9/1/26 Free

General Counsel

7,405 0.0050%
8/4/26 Sell

Director

-593 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+3.68%-0.71%+70.46%+6.25% 36.08B
+6.88%+4.71%+68.19%+141.87% 1,148B
+1.34%+2.68%+47.26%+86.89% 652B
+1.21%+1.49%+28.56%+103.98% 505B
+0.80%+2.47%+54.30%+66.51% 384B
+4.92%+0.10%+70.24%+43.54% 348B
+2.56%+2.73%+34.42%+56.45% 294B
+2.37%+0.40%+3.76%+27.54% 264B
+1.66%+2.50%+57.12%+74.19% 244B
+1.44%+2.68%+36.20%+107.54% 197B
Average +2.68%+1.38%+47.05%+71.48% 407.32B
Weighted average by Cap. +3.32%+1.50%+49.98%+92.38%

Financials

2026 *2027 *
Net sales 10.51B 9.43B 8.72B 7.9B 14.76B 1,001B 14.93B 104B 41.53B 524B 39.45B 38.62B 1,663B 10.71B 9.61B 8.88B 8.04B 15.03B 1,020B 15.21B 106B 42.3B 534B 40.18B 39.33B 1,694B
Net income 856M 768M 710M 643M 1.2B 81.56B 1.22B 8.49B 3.38B 42.68B 3.21B 3.15B 135B 1.77B 1.59B 1.47B 1.33B 2.49B 169B 2.52B 17.6B 7.01B 88.44B 6.66B 6.52B 281B
Net Debt 6.16B 5.52B 5.11B 4.62B 8.64B 586B 8.74B 61.05B 24.32B 307B 23.1B 22.61B 974B 3.04B 2.72B 2.52B 2.28B 4.26B 289B 4.31B 30.12B 12B 151B 11.4B 11.15B 480B
Projected Income Statement - Annual - Biogen Inc.
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
26-10-29 $251.81 +3.18% 327,967
26-10-28 $244.05 -3.43% 2,493,008
26-10-27 $252.73 +0.19% 1,393,391
26-10-26 $252.26 +0.63% 958,847
26-10-23 $250.69 -1.24% 1,157,376
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Biogen Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
244.05USD
Average target price
261.35USD
Spread / Average Target
+7.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Biogen Inc.
  1. Stock Market
  2. Stocks
  3. BIIB Stock